Cargando…
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
BACKGROUND: Non-alcoholic steatohepatitis (NASH) is highly associated with metabolic syndrome, a major cause of morbidity in the globalized society. The renin–angiotensin system (RAS) influences hepatic fatty acid metabolism, inflammation and fibrosis. Thus, in the present study, we aimed to evaluat...
Autores principales: | Ramalho, F. N., Sanches, S. C., Foss, M. C., Augusto, M. J., Silva, D. M., Oliveira, A. M., Ramalho, L. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640954/ https://www.ncbi.nlm.nih.gov/pubmed/29046730 http://dx.doi.org/10.1186/s13098-017-0282-5 |
Ejemplares similares
-
Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
por: Sanches, Sheila Cristina L., et al.
Publicado: (2015) -
Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats
por: Chou, Chu-Lin, et al.
Publicado: (2011) -
Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010) -
A New Rodent Model of Non-Alcoholic Steatohepatitis and Metabolic Syndrome
por: Romeiro, Fernando Gomes, et al.
Publicado: (2019) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)